Evidence map›Paper›PMID 39687830›Full record

ArticleCureus2024

Quality Assessment of Functional Claims of Salacia-Derived Salacinol-Containing Foods.

Kazumi Kuribayashi, Takahiro Amemiya, Toshikazu Seino, Takashi Tomita

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kazumi KuribayashiDepartment of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, JPN.
Takahiro AmemiyaDepartment of Pharmacy, Sanno Hospital, Minato-ku, JPN.
Toshikazu SeinoDepartment of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, JPN.
Takashi TomitaDepartment of Pharmaceutical Sciences, School of Pharmacy at Narita, International University of Health and Welfare, Narita-shi, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Functional claim-associated foods contain raw materials that contribute to enhancing health in Japan. However, certain foods with functional claims fail to meet the disintegration test (DT) criteria of the Japanese Pharmacopoeia (JP). Objective This study assessed the quality of tablet-type, functional claim-associated foods containing Salacia-derived salacinol, using DT and weight variation (WV) tests. Methods DT and WV were conducted on functional foods (A, B, and C) sourced from three companies using samples stored either at room temperature (RT: 22-27 ℃) or in an incubator at 40 ± 2 °C and 75% ± 5% in relative humidity accelerated conditions (AC) for one, two, and four weeks, respectively. Results Samples A and C were compliant under all WV test conditions, whereas sample B was compliant except when stored in AC. DT results indicated compliance for sample A upon immediate opening and on storing for two and four weeks at RT, sample B for four weeks at RT, and sample C upon immediate opening, all AC, and stored for two and four weeks at RT. Conclusions Varied disintegration times may affect the release of functionally active ingredients into the body and their absorption from the gastrointestinal tract, potentially compromising their intended health benefits.

Indexed as

disintegration testfunctional claims foodjapanese pharmacopoeiasalacia derived salacinolweight variation test

Identifiers

PMID39687830
PMCPMC11647744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.